NCT07776691 · Interventional trial
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Overall registry status Recruiting
Phase 3
Conditions Fallopian Tube Cancer, Ovarian Cancer, Ovarian Neoplasms, Peritoneal Cancer
Delaware Valley sites
- Alliance Cancer Specialists (ACS) ( Site 8008) · Horsham, PA · Montgomery County · Recruiting
First posted
Registry updated
Added to the directory